• Info
  • Insider Ownership

Insider Trading & Ownership of WILLIAM F. DOYLE

Summary
The estimated net worth of WILLIAM F. DOYLE is at least $8,375,667 dollars as of 02 Jun 2025. WILLIAM F. DOYLE is the Executive Chairman, Director of NovoCure Ltd and owns shares of NovoCure Ltd (NVCR) stock worth about $6,972,376. WILLIAM F. DOYLE is the Director of Elanco Animal Health Inc and owns shares of Elanco Animal Health Inc (ELAN) stock worth about $1,403,291.
Signature
/s/ Todd Girolamo, attorney in fact
All Insider Reports
All Insider Reports

Notify me when WILLIAM F. DOYLE files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of WILLIAM F. DOYLE

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NVCR NovoCure Ltd Executive Chairman, Director $6,972,376 02 Aug 2022
ELAN Elanco Animal Health Inc Director $1,403,291 29 Nov 2024
NERV Minerva Neurosciences, Inc. Director 10 Jun 2022
PROK PROKIDNEY CORP. Director 29 May 2025

Insider Transactions Reported by WILLIAM F. DOYLE:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.